Back to search

Aveo Pharma Limited

06456614

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk

No risk factors detected.

Details

5TH FLOOR HALO, BRISTOL, BS1 6AJ
Incorporated 18/12/2007

Compliance

Last accounts

31/12/2024

dormant

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 18/12/2025

Due 01/01/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Michael Bailey

director · Since 30/01/2015

PRESIDENT & CEO OF AVEO PHARMACETICALS

AMERICAN · UNITED STATES · Age 60

Danielle Holland

director · Since 23/02/2023

COMPANY DIRECTOR

AMERICAN · UNITED STATES · Age 40

Persons with Significant Control

Former PSCs

Aveo Pharmaceuticals, Inc.

Ceased 19/01/2023

CompanyRankvs 944+ SIC 72110 peers
63

Financial strength90th percentile among SIC peers · 23/25
Employees66th percentile among SIC peers · 10/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£646k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

Working capital

Current Assets

Current Liabilities

Debtors

£646k

2avg. employees

Balance Sheet

Assets less current liabilities£646k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearImplied Profit
2024+£0
2023+£0
2022+£0
2021+£0
2020+£0

Derived from filed accounts. Not audited figures.